Press Releases

Date Description  
Mar 30, 2015
Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement
MINNEAPOLIS  and ORANGEBURG, N.Y.,  March 30, 2015  /PRNewswire/ --  Uroplasty, Inc.  (NASDAQ: UPI) and  Vision-Sciences, Inc.  (NASDAQ: VSCI) shareholders have voted at the special meeting of each company's shareholders held today to approve the
Mar 3, 2015
Uroplasty to Host Investor Meeting at Corporate Headquarters

March 12th Event to Feature Urologist Perspective on the Use of Uroplasty and Vision-Sciences Product Lines

Feb 27, 2015
Uroplasty to Participate in the 27th Annual ROTH Conference
Uroplasty to Participate in the 27th Annual ROTH Conference MINNEAPOLIS , Feb. 27, 2015 /PRNewswire/ --  Uroplasty, Inc.  (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced that it
Feb 24, 2015
Uroplasty Announces Positive Coverage Decision For Percutaneous Tibial Nerve Stimulation By Cigna
Uroplasty Announces Positive Coverage Decision For Percutaneous Tibial Nerve Stimulation By Cigna   MINNEAPOLIS ,  Feb. 24, 2015  /PRNewswire/ --  Uroplasty, Inc.  (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary
Feb 4, 2015
Vision-Sciences Reports Financial Results for Third Quarter and First Nine Months of Fiscal 2015
ORANGEBURG, NY -- (Marketwired) -- 02/04/15 -- Vision-Sciences, Inc. (NASDAQ: VSCI), a leading provider of unique flexible endoscopic products, today announced financial results for the three- and nine-month periods ended December 31, 2014 . Third Quarter Fiscal 2015 Highlights Net sales increased
Jan 22, 2015
Vision-Sciences to Host Third Quarter Fiscal 2015 Results Call
ORANGEBURG, NY / ACCESSWIRE / January 22, 2015 / Vision-Sciences, Inc. (Nasdaq: VSCI), a leading provider of unique flexible endoscopic products utilizing its proprietary sterile disposable EndoSheath(R) technology, today announced that the Company will release its financial results for the third
Jan 22, 2015
Uroplasty Reports Record Revenue in Fiscal Third Quarter

~ Global Urgent PC Sales Up 14.5%
~~ Proposed Merger with Vision-Sciences to Expand Innovation in Product Portfolio

Jan 14, 2015
Uroplasty To Announce Third Quarter Fiscal Year 2015 Financial Results On January 22, 2015
Uroplasty To Announce Third Quarter Fiscal Year 2015 Financial Results On January 22, 2015   MINNEAPOLIS ,  Jan. 14, 2015  /PRNewswire/ --  Uroplasty, Inc.  (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products for
Dec 29, 2014
New Research Study by the Mayo Clinic Finds Sedation-Free TNE With EndoSheath® Technology May Provide an Effective Alternative to Standard Upper Endoscopy Procedures

Mobile Screening With Transnasal Esophagoscopy May Allow For Potential Use in Strategy to Reduce Esophageal Cancer Mortality

Dec 22, 2014
Uroplasty and Vision-Sciences to Merge, Creating Innovative Medical Device Company Positioned for Growth
All-Stock Combination Creates New Company with Expanded Product Offerings in Urology Conference Call Today at 11:00 AM EST MINNEAPOLIS and ORANGEBURG, N.Y., Dec. 22, 2014 (GLOBE NEWSWIRE) -- Uroplasty, Inc. (Nasdaq:UPI) and Vision-Sciences, Inc. (Nasdaq:VSCI) entered into a definitive merger
Displaying 51 - 60 of 74